Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Samaneh MOALLEMI"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Brucellosis is a difficult to treat infection that requires antibiotic combinations administered over several weeks for clearance of infection and relapse prevention. This systematic review summarizes current evidence for antibiotic treatmen
Externí odkaz:
https://doaj.org/article/0d4aac847f7442e8a23b69b5e01dd2e6
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-16 (2023)
Abstract Early identification of dengue patients at risk of adverse outcomes is important to prevent hospital overcrowding in low- to middle- income countries during epidemics. We performed a systematic review to identify which biomarkers measured in
Externí odkaz:
https://doaj.org/article/c1abdb51776047fe9b0f09c3c0036c42
Autor:
Molood FARROKHI, Samaneh MOALLEMI, Reza SHIRKOOHI, Reza GOLMOHAMMADI, Sara AHSANI-NASAB, Sara SARDASHTI, Ladan ABBASIAN, Kazem BAESI, Minoo MOHRAZ
Publikováno v:
Iranian Journal of Public Health, Vol 46, Iss 9 (2017)
Background: This study aimed to determine drug resistance mutations in patients with virological failure and find correlation between HIV drug resistance test and viral load. Methods: Blood sample was collected from 51 patients who suspicious treatm
Externí odkaz:
https://doaj.org/article/c5625ca62ffe4cf7bfa3a71da5a03b43
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e105098 (2014)
BACKGROUND: The rate of human immunodeficiency virus type 1 (HIV-1) infection in Iran has increased dramatically in the past few years. While the earliest cases were among hemophiliacs, injection drug users (IDUs) fuel the current epidemic. Previous
Externí odkaz:
https://doaj.org/article/55062d37d05e42e8a6070a6adcdbe33a
Autor:
Leila Sadeghi, Kazem Baesi, Mohammad Reza Gholami, Minoo Mohraz, Molood Farrokhi, Samaneh Moallemi, Sara Ahsani-Nasab
Publikováno v:
Intervirology. 59:131-136
Background: Increasing the accessibility of antiretroviral therapy (ART) has caused the emergence of drug resistance in patients receiving ART and in naïve patients. The aim of this study was to evaluate HIV subtype and drug resistance between naïv
Autor:
Mehrdad Hasibi, Farzaneh Sabahi, Kazem Baesi, Katayoon Tayeri, Saber Kalhori, M. Gholami, Samaneh Moallemi, Marzyeh Nili
Publikováno v:
Infectious disorders drug targets. 19(1)
Background: The rate of human immunodeficiency virus type 1 (HIV-1) infection in Iran has increased dramatically in the past few years. HIV-1 genome sequences are pivotal for large-scale studies of inter- and intra-host evolution. To understand the m
Autor:
Sara Ahsani-Nasab, Niloofar Eghbal Ahmadi, Saeed Bayanolhagh, Minoo Mohraz, Samaneh Moallemi, Arsalan Narouei, Masoomeh Lolaie, Reza Adl Tabatabai, SeyedAhmad SeyedAlinaghi, Ali Esmaeilzadeh, Leila Sadeghi
Publikováno v:
Infectious disorders drug targets. 18(3)
BACKGROUND The initial antiretroviral therapy (ART) regimens recommended by most national treatment guidelines in resource-limited settings consist of two Nucleoside Reverse-Transcriptase Inhibitors (NRTIs) and one Non-Nucleoside Reverse- Transcripta
Publikováno v:
Asian Pacific Journal of Tropical Disease, Vol 4, Iss Sup 2, Pp 617-620 (2014)
Objective To identify the dominant subtype among the HIV-1 strains circulation in Iran. Methods In this cross sectional study 100 HIV positive patients participated. HIV-1 RNA was extracted from plasma. RT nested-PCR was performed and the final produ
Publikováno v:
Molekuliarnaia biologiia. 50(2)
MicroRNAs (miRNAs) are small non-coding RNA molecules, which have an important function in regulating RNA stability and gene expression. They also can circulate in a cell-free form in the blood thatmakes them potential disease markers. The liver cont
Autor:
Samaneh Moallemi, Molood Farrokhi, Hong-Ha M. Truong, Kazem Baesi, Seyed Ahmad Seyed Alinaghi
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 9, p e105098 (2014)
PLoS ONE, Vol 9, Iss 9, p e105098 (2014)
Background The rate of human immunodeficiency virus type 1 (HIV-1) infection in Iran has increased dramatically in the past few years. While the earliest cases were among hemophiliacs, injection drug users (IDUs) fuel the current epidemic. Previous m